Nevilast 40 Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Nevilast 40 Tablet is a fixed-dose antiretroviral combination of lamivudine and stavudine (nucleoside reverse transcriptase inhibitors) with nevirapine (a non-nucleoside reverse transcriptase inhibitor). Its labelling describes it for the treatment of HIV-1 infection, given alone or with other medicines, and it is described as reducing the viral load and supporting recovery of the immune system.
Product Information
The following description reflects information associated with lamivudine, nevirapine, and stavudine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of HIV-1 infection, given alone or in combination with other medicines
- Described as inhibiting the reverse transcriptase enzyme that HIV needs to replicate
- Described as reducing the viral load and helping the immune system improve
Described Dosage & Administration
- The prescriber decides the dose based on the patient’s health reports and other factors
- Tablets should not be crushed or chewed
- A missed dose should be taken as soon as it is remembered; the prescriber decides whether it is taken with or without food
Described Side Effects
Commonly described side effects include:
- Headache
- Diarrhoea
- Rash
- Difficulty sleeping (insomnia)
- Dry mouth
- Fever
These are described as commonly not long-lasting. Serious effects — including liver injury and severe skin reactions — are described as needing immediate medical attention.
Precautions
- The doctor should be told about all other medicines being taken that might interfere with this medicine
- Serious effects such as liver injury and severe skin reactions require immediate medical attention
- Pregnant women and breastfeeding mothers should consult their doctor before starting the medicine
- Any persistent or worsening side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it combines lamivudine, nevirapine, and stavudine for the treatment of HIV-1 infection, given alone or with other medicines, and described as reducing the viral load and helping the immune system improve. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken at the dose set by the prescriber based on the patient’s health reports, not crushed or chewed, with the prescriber deciding whether it is taken with or without food.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.